A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 6 January 2024) has been published and includes articles on:
Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): new safety and educational materials to support regulatory measures in men and women under 55 years of age
Fluoroquinolone antibiotics: must now only be prescribed when other commonly recommended antibiotics are inappropriate
Omega-3-acid ethyl ester medicines (Omacor/Teromeg 1000mg capsules): dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors
Letters and medicine recalls sent to healthcare professionals in December 2023.
To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website.
The post MHRA Drug Safety Update: January 2024 appeared first on Community Pharmacy England.